论文部分内容阅读
目的:探究泮托拉唑与康复新液联合治疗十二指肠球部溃疡的效果。方法:选取2016年6月-2017年2月期间我院收治的十二指肠球部溃疡患者80例作为研究对象,按照入院顺序进行均等分组,参照组(n=40,给予泮托拉唑治疗)及实验组(n=40,泮托拉唑联合康复新液治疗),观察两组溃疡愈合效果、不良反应情况。结果:研究组总有效率为95.00%(38/40),参照组为85.00%(34/40),(P<0.05);研究组不良反应例数为1例(2.50%),参照组为5例(12.50%),组间对比差异显著(P<0.05)。结论:泮托拉唑联合康复新液治疗十二指肠球部溃疡,可以显著治愈溃疡,不良反应发生少,值得临床推广。
Objective: To investigate the effect of Pantoprazole and Kangfuxin Solution in treating duodenal ulcer. Methods: Totally 80 patients with duodenal ulcer admitted in our hospital from June 2016 to February 2017 were selected as research subjects and were divided into groups according to admission order. The patients in the reference group (n = 40, given pantoprazole Treatment) and experimental group (n = 40, pantoprazole combined with rehabilitation Fu liquid treatment), the two groups observed the healing effect of ulcers, adverse reactions. Results: The total effective rate was 95.00% (38/40) in the study group and 85.00% (34/40) in the reference group (P <0.05). The number of adverse reactions in the study group was 1 case (2.50% 5 cases (12.50%), the difference between groups was significant (P <0.05). Conclusion: The combination of pantoprazole and kangfuxin liquid in the treatment of duodenal ulcer can cure ulcers remarkably with fewer adverse reactions and is worthy of clinical promotion.